{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:59:50Z","timestamp":1773226790013,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,6,14]],"date-time":"2004-06-14T00:00:00Z","timestamp":1087171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The development of novel vaccine strategies to replace or supplement bacille Calmette\u2013Gu\u00e9rin (BCG) is urgently required. Here we study, in cattle, the use of heterologous prime\u2013boost strategies based on vaccination with BCG and the mycobacterial mycolyl transferase Ag85A (Rv3804c) expressed either in recombinant modified vaccinia virus Ankara (MVA85A) or attenuated fowlpox strain FP9 (FP85A). Five different vaccination schedules were tested in the first experiment: MVA85A followed by BCG (group 1); BCG followed by MVA85A (group 2); BCG followed by FP85A and then MVA85A (group 3); MVA85A followed by MVA85A and then FP85A (group 4); and FP85A followed by FP85A and then MVA85A (group 5). Vaccine\u2010induced levels of cellular immunity were assessed by determining interferon\u2010\u03b3 (IFN\u2010\u03b3) responses <jats:italic>in vitro<\/jats:italic>. Prime\u2013boost protocols, using recombinant MVA and BCG in combination (groups 1\u20133), resulted in significantly higher frequencies of Ag85\u2010specific IFN\u2010\u03b3\u2010secreting cells than the two viral vectors used in combination (<jats:italic>P<\/jats:italic>=0\u00b70055), or BCG used alone (groups 2 and 3, <jats:italic>P<\/jats:italic>=0\u00b704). The T\u2010cell repertoires of the calves in all five groups were significantly broader following heterologous booster immunizations than after the primary immunization. In a second experiment, the effects of BCG\\MVA85A heterologous prime\u2013boost vaccination were compared with BCG\\BCG homologous revaccination. The results suggested a higher Ag85A\u2010specific response with a wider T\u2010cell repertoire in the MVA85A\u2010boosted calves than in the BCG\\BCG\u2010vaccinated calves. In conclusion therefore, the present report demonstrates the effectiveness of heterologous prime\u2013boost strategies based on recombinant MVA and BCG to induce strong cellular immune responses in cattle and prioritise such vaccination strategies for rapid assessment of protective efficacy in this natural target species of tuberculosis.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2004.01903.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T01:03:54Z","timestamp":1104109434000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Cellular immune responses induced in cattle by heterologous prime\u2013boost vaccination using recombinant viruses and bacille Calmette\u2013Gu\u00e9rin"],"prefix":"10.1111","volume":"112","author":[{"given":"H. Martin","family":"Vordermeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley G.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilu","family":"Goonetilleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Glyn","family":"Hewinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,14]]},"reference":[{"key":"e_1_2_19_2_2","first-page":"169","volume-title":"Mycobacterium bovis Infection in Animals and Humans.","author":"Steele JH","year":"1995"},{"key":"e_1_2_19_3_2","volume-title":"Bovine Tuberculosis in Cattle and Badgers.","author":"Krebs JR","year":"1997"},{"key":"e_1_2_19_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(02)00062-8"},{"key":"e_1_2_19_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S353"},{"key":"e_1_2_19_6_2","volume-title":"Bovine Tuberculosis","author":"Francis J","year":"1947"},{"key":"e_1_2_19_7_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.6.1.1-5.1999","article-title":"Differentiation between Mycobacterium bovis BCG\u2010vaccinated and M. bovis\u2010infected cattle by using recombinant mycobacterial antigens","volume":"6","author":"Buddle BM","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_19_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.3.571-578.2001"},{"key":"e_1_2_19_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6996-7003.2002"},{"key":"e_1_2_19_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01589.x"},{"key":"e_1_2_19_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.4174-4176.2001"},{"key":"e_1_2_19_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.681-686.2001"},{"key":"e_1_2_19_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.3041-3047.2001"},{"key":"e_1_2_19_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.6.2951-2959.1998"},{"key":"e_1_2_19_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-893"},{"key":"e_1_2_19_16_2","first-page":"483","article-title":"What's new in tuberculosis vaccines?","volume":"80","author":"Ginsberg AM","year":"2002","journal-title":"Bull World Health Organ"},{"key":"e_1_2_19_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00449.x"},{"key":"e_1_2_19_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.5.2573-2578.2000"},{"key":"e_1_2_19_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00944.x"},{"key":"e_1_2_19_20_2","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism","volume":"167","author":"Mayr A","year":"1978","journal-title":"Zentralbl Bakteriol [B]"},{"key":"e_1_2_19_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11341"},{"key":"e_1_2_19_22_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-10-2661"},{"key":"e_1_2_19_23_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.93"},{"key":"e_1_2_19_24_2","doi-asserted-by":"publisher","DOI":"10.1054\/tube.2000.0254"},{"key":"e_1_2_19_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(02)00017-X"},{"key":"e_1_2_19_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.5.12.3403"},{"key":"e_1_2_19_27_2","first-page":"25","article-title":"EEC directive 80\/219, amending directive 64\/432 annexe B","volume":"047","author":"European Economic Community.","year":"1980","journal-title":"Official J"},{"key":"e_1_2_19_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(87)90077-5"},{"key":"e_1_2_19_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.1.483-493.2003"},{"key":"e_1_2_19_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.3026-3032.2002"},{"key":"e_1_2_19_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.1980-1987.2003"},{"key":"e_1_2_19_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00238-3"},{"key":"e_1_2_19_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.9.5604"},{"key":"e_1_2_19_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.3.1095"},{"key":"e_1_2_19_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni969"},{"key":"e_1_2_19_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni872"},{"key":"e_1_2_19_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80470-7"},{"key":"e_1_2_19_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01218.x"},{"key":"e_1_2_19_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307158101"},{"key":"e_1_2_19_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.3.1602"},{"key":"e_1_2_19_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"e_1_2_19_42_2","first-page":"15","article-title":"[BCG revaccination of school children in circumstances of low incidence of tuberculosis]","volume":"1","author":"Lebedeva LV","year":"1992","journal-title":"Probl Tuberk"},{"key":"e_1_2_19_43_2","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung CC","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_19_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90043-J"},{"key":"e_1_2_19_45_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.4.9706037"},{"key":"e_1_2_19_46_2","first-page":"15","article-title":"Analysis of the efficacy of mass BCG vaccination from 1959 to 1983 in tuberculosis control in Hungary. Multiple comparison of results","volume":"62","author":"Lugosi L","year":"1987","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"e_1_2_19_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.4.1527-1533.1998"},{"key":"e_1_2_19_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.11.1669"},{"key":"e_1_2_19_49_2","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.158.12.5921","article-title":"Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection","volume":"158","author":"Zhu X","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_19_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri724"},{"key":"e_1_2_19_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.12.6906-6914.2003"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2004.01903.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2004.01903.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:15:45Z","timestamp":1697235345000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2004.01903.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,14]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2567.2004.01903.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01903.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,14]]},"assertion":[{"value":"2004-06-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}